<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03071497</url>
  </required_header>
  <id_info>
    <org_study_id>468/16</org_study_id>
    <nct_id>NCT03071497</nct_id>
  </id_info>
  <brief_title>Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX</brief_title>
  <official_title>Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  In approx. 40% of the incidences anemia is caused by iron deficiency (= ID). In turn,&#xD;
           preoperative iron-deficiency anemia (= IDA) is associated with an increase in morbidity&#xD;
           and mortality as well as with the need for a blood transfusion.&#xD;
&#xD;
        -  A successful preoperative treatment of IDA via iron supplementation requires a timely&#xD;
           screening of iron deficiency, typically done by analyzing specific blood parameters.&#xD;
           This however of course requires drawing a blood sample which further reduces the&#xD;
           patients' blood volume and is in many cases stated as an inconvenient procedure.&#xD;
&#xD;
        -  Measured in blood zinc protoporphyrin-IX (= ZnPP) is an established parameter to detect&#xD;
           ID.&#xD;
&#xD;
        -  This study aims to evaluate a prototype device detecting ZnPP non-invasively in the&#xD;
           intact oral mucosa of surgical patients.&#xD;
&#xD;
        -  Results from the non-invasive measurement will be compared to reference measurements of&#xD;
           ZnPP from residual blood samples (HPLC analysis) as well as to other parameters&#xD;
           including Hb level and iron profile (MCH [= mean corpuscular hemoglobin], MCV [= mean&#xD;
           corpuscular volume], ferritin, transferrin, transferrin saturation, soluble transferrin&#xD;
           receptor, CRP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The non-invasive measurements will be performed using a prototype device based on&#xD;
      fluorescence spectroscopical techniques. In brief, light (restricted wavelengths: 407 /&#xD;
      425nm) will be used to excite ZnPP molecules within the blood of the oral mucosa by means of&#xD;
      an optical fibre prob. The outgoing fluorescence emission of the excited molecules will be&#xD;
      analyzed using a spectrometer and converted to a ZnPP value [unit: µmol/mol heme] using&#xD;
      mathematical transformations as well as spectral fitting.&#xD;
&#xD;
      This study compares the diagnostic performance of iron deficiency based on non-invasive&#xD;
      measurements of Zinc protoporphyrin with results based on standard laboratory procedure (i.e.&#xD;
      ZnPP measured in whole blood sample using HPLC) and blood values assessed during clinical&#xD;
      routine, respectively.&#xD;
&#xD;
      If results of non-invasive and reference measurement techniques yield coinciding results, the&#xD;
      non-invasive method could provide an improved mean to detect iron deficiency and thereby to&#xD;
      improve treatment of patients suffering from iron deficiency anemia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 3, 2017</start_date>
  <completion_date type="Actual">May 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Zinc protoporphyrin blood concentration (non-invasive measurement)</measure>
    <time_frame>Baseline</time_frame>
    <description>Using the prototype device Zinc protoporphyrin blood concentration [unit: µmol/mol heme] will be measured non-invasively in the oral mucosa.&#xD;
Concentrations will be compared (Spearman's Rho, sensitivity, specificity) with Zinc protoporphyrin measurements of whole blood samples (see outcome 2 and 3).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Zinc protoporphyrin blood concentration (HPLC reference measurement)</measure>
    <time_frame>Baseline</time_frame>
    <description>Using HPLC, the analytical reference method, Zinc protoporphyrin blood concentration [unit: µmol/mol heme] will be measured in whole blood samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zinc protoporphyrin blood concentration (spectroscopic measurement)</measure>
    <time_frame>Baseline</time_frame>
    <description>Using fluorescence spectroscopic methods Zinc protoporphyrin blood concentration [unit: µmol/mol heme] will be measured in whole blood samples.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemoglobin levels [unit: g/dL] will be assessed from blood samples using standardized laboratory techniques.&#xD;
Hemoglobin levels will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>MCH</measure>
    <time_frame>Baseline</time_frame>
    <description>MCH (= mean corpuscular hemoglobin) [unit: pg] will be assessed from blood samples using standardized laboratory techniques.&#xD;
MCH will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>MCV</measure>
    <time_frame>Baseline</time_frame>
    <description>MCV (= mean cell volume) [unit: fL = femtoliter] will be assessed from blood samples using standardized laboratory techniques.&#xD;
MCV will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>Ferritin</measure>
    <time_frame>Baseline</time_frame>
    <description>Ferritin [unit: µg/L] will be assessed from blood samples using standardized laboratory techniques.&#xD;
Ferritin levels will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>CRP</measure>
    <time_frame>Baseline</time_frame>
    <description>CRP (= C-reactive protein) [unit: mg/dL] will be assessed from blood samples using standardized laboratory techniques.&#xD;
CRP will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>Transferrin saturation</measure>
    <time_frame>Baseline</time_frame>
    <description>Transferrin saturation [unit: %] will be assessed from blood samples using standardized laboratory techniques.&#xD;
Transferrin saturation will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <other_outcome>
    <measure>Soluble transferrin receptor</measure>
    <time_frame>Baseline</time_frame>
    <description>Soluble Transferrin receptor [unit: mg/L] will be assessed from blood samples using standardized laboratory techniques.&#xD;
Soluble transferrin receptor will be compared with non-invasive Zinc protoporphyrin measurements (Spearman's Rho, sensitivity, specificity).</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Iron-deficiency</condition>
  <condition>Anemia</condition>
  <condition>Iron Deficiency Anemia</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <description>Detecting iron deficiency using various methods. All patients that fit the inclusion criteria and are willing to participate in the study will be included in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-invasive analysis of Zinc protoporphyrin</intervention_name>
    <description>In patients fitting the inclusion criteria Zinc protoporphyrin will be measured non-invasively as proxy for iron deficiency. Results will be compared to ZnPP reference values measured via HPLC and with spectroscopical measurements performed on whole blood as well as with blood values (HB, MCH, MCV, ferritin, CRP, transferrin saturation, soluble transferrin receptor) assessed during clinical routine.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients preoperatively screened for anemia in the anemia walk-in clinic of the&#xD;
        University Hospital Frankfurt that fit the inclusion criteria will be asked to participate&#xD;
        in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who received a blood transfusion less than 8 weeks before examination&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Meybohm, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johann Wolfgang Goethe University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University Hospital</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hesse</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>February 25, 2017</study_first_submitted>
  <study_first_submitted_qc>March 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2017</study_first_posted>
  <last_update_submitted>July 14, 2018</last_update_submitted>
  <last_update_submitted_qc>July 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Patrick Meybohm, M.D.</investigator_full_name>
    <investigator_title>Prof. Dr. Patrick Meybohm</investigator_title>
  </responsible_party>
  <keyword>Iron-deficiency</keyword>
  <keyword>Anemia</keyword>
  <keyword>Iron-deficiency Anemia</keyword>
  <keyword>Zinc protoporphyrin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Protoporphyrin IX</mesh_term>
    <mesh_term>Zinc protoporphyrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

